Management of STEC Gastroenteritis: Is There a Role for Probiotics?
Abstract
:1. Introduction
1.1. Shiga Toxin-Producing Escherichia Coli (STEC) Gastroenteritis and Hemolytic Uremic Syndrome
1.2. The Human Gut Microbiota
2. Methods
3. Probiotics
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
Abbreviations
AKI | Acute Kidney Injury |
CKD | Chronic Kidney Disease |
ESRD | End-Stage Renal Disease |
EHEC | Enterohemorrhagic Escherichia coli |
HUS | Hemolytic Uremic Syndrome |
STEC | Shiga-toxin-producing Escherichia coli |
STX | Shiga toxin |
References
- Tsai, H.-M. Untying the Knot of Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome. Am. J. Med. 2013, 126, 200–209. [Google Scholar] [CrossRef] [PubMed]
- Kappler, S.; Ronan-Bentle, S.; Graham, A. Thrombotic Microangiopathies (TTP, HUS, HELLP). Hematol. Oncol. Clin. N. Am. 2017, 31, 1081–1103. [Google Scholar] [CrossRef] [PubMed]
- Freedman, S.B.; Eltorki, M.; Chui, L.; Xie, J.; Feng, S.; MacDonald, J.; Dixon, A.; Ali, S.; Louie, M.; Lee, B.E.; et al. Province-Wide Review of Pediatric Shiga Toxin-Producing Escherichia coli Case Management. J. Pediatr. 2017, 180, 184–190. [Google Scholar] [CrossRef] [PubMed]
- Tarr, P.I.; Gordon, C.A.; Chandler, W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365, 1073–1086. [Google Scholar] [CrossRef]
- Müthing, J.; Schweppe, C.H.; Karch, H.; Friedrich, A.W. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 2009, 101, 252–264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Melton-Celsa, A.R. Shiga Toxin (Stx) Classification, Structure, and Function. Microbiol. Spectr. 2014, 2, EHEC-0024-2013. [Google Scholar] [CrossRef] [PubMed]
- Morigi, M.; Galbusera, M.; Binda, E.; Imberti, B.; Gastoldi, S.; Remuzzi, A.; Zoja, C.; Remuzzi, G. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 2001, 98, 1828–1835. [Google Scholar] [CrossRef] [Green Version]
- Ruggenenti, P.; Noris, M.; Remuzzi, G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001, 60, 831–846. [Google Scholar] [CrossRef] [Green Version]
- Ardissino, G.; Tel, F.; Possenti, I.; Testa, S.; Consonni, D.; Paglialonga, F.; Salardi, S.; Borsa-Ghiringhelli, N.; Salice, P.; Tedeschi, S.; et al. Early Volume Expansion and Outcomes of Hemolytic Uremic Syndrome. Pediatrics 2016, 137, e20152153. [Google Scholar] [CrossRef]
- Hickey, C.A.; Beattie, T.J.; Cowieson, J.; Miyashita, Y.; Strife, C.F.; Frem, J.C.; Peterson, J.M.; Butani, L.; Jones, D.P.; Havens, P.L.; et al. Early Volume Expansion During Diarrhoea and Relative Nephroprotection During Subsequent Hemolytic Uremic Syndrome. Arch. Pediatr. Adolesc. Med. 2011, 165, 884–889. [Google Scholar] [CrossRef] [PubMed]
- Giordano, P.; Netti, G.S.; Santangelo, L.; Castellano, G.; Carbone, V.; Torres, D.D.; Martino, M.; Sesta, M.; Di Cuonzo, F.; Resta, M.C.; et al. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr. Nephrol. 2019, 34, 517–527. [Google Scholar] [CrossRef]
- Germinario, C.; Caprioli, A.; Giordano, M.; Chironna, M.; Gallone, M.S.; Tafuri, S.; Minelli, F.; Maugliani, A.; Michelacci, V.; Santangelo, L.; et al. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013. Eurosurveillance 2016, 21, 30343. [Google Scholar] [CrossRef] [PubMed]
- Bielaszewska, M.; Mellmann, A.; Zhang, W.; Köck, R.; Fruth, A.; Bauwens, A.; Peters, G.; Karch, H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: A microbiological study. Lancet Infect. Dis. 2011, 11, 671–676. [Google Scholar] [CrossRef]
- Zoja, C.; Buelli, S.; Morigi, M. Shiga toxin triggers endothelial and podocyte injury: The role of complement activation. Pediatr. Nephrol. 2019, 34, 379–388. [Google Scholar] [CrossRef]
- Noris, M.; Remuzzi, G. Hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2005, 16, 1035–1050. [Google Scholar] [CrossRef] [PubMed]
- Spinale, J.M.; Ruebner, R.L.; Copelovitch, L.; Kaplan, B.S. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr. Nephrol. 2013, 28, 2097–2105. [Google Scholar] [CrossRef] [PubMed]
- Garg, A.X.; Suri, R.S.; Barrowman, N.; Rehman, F.; Matsell, D.; Rosas-Arellano, M.P.; Salvadori, M.; Haynes, R.B.; Clark, W.F. Long-term Renal Prognosis of Diarrhoea-Associated Hemolytic Uremic Syndrome. JAMA 2003, 290, 1360–1370. [Google Scholar] [CrossRef]
- Luzzi, I.; García-Fernández, A.; Dionisi, A.M.; Lucarelli, C.; Gattuso, A.; Gianfranceschi, M.; Maugliani, A.; Caprioli, A.; Morabito, S.; Scavia, G. Enter-Net Italia and the Italian Registry of Hemolytic Uremic Syndrome: Surveillance of Salmonella,Campylobacter, Shiga-Toxin Producer Escherichia coli and Listeria Monocytogenes Infections (2010–2015); Reports of Italian Institute of Health (Rapporti ISTISAN); Italian Institute of Health: Rome, Italy, 2017; p. 70. (In Italian) [Google Scholar]
- Majowicz, S.E.; Scallan, E.; Jones-Bitton, A.; Sargeant, J.M.; Stapleton, J.; Angulo, F.J.; Yeung, D.H.; Kirk, M.D. Global Incidence of Human Shiga Toxin–Producing Escherichia coli Infections and Deaths: A Systematic Review and Knowledge Synthesis. Foodborne Pathog. Dis. 2014, 11, 447–455. [Google Scholar] [CrossRef] [Green Version]
- Indrio, F.; Di Mauro, A.; Riezzo, G.; Di Mauro, F.; Francavilla, R. Microbiota in healthy term infant. Early Hum. Dev. 2013, 89, S15–S17. [Google Scholar] [CrossRef]
- Di Mauro, A.; Neu, J.; Riezzo, G.; Raimondi, F.; Martinelli, D.; Francavilla, R.; Indrio, F. Gastrointestinal function development and microbiota. Ital. J. Pediatr. 2013, 39, 15. [Google Scholar] [CrossRef]
- Ubeda, C.; Djukovic, A.; Isaac, S. Roles of the intestinal microbiota in pathogen protection. Clin. Transl. Immunol. 2017, 6, e128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lei, Y.M.K.; Nair, L.; Alegre, M.-L. The interplay between the intestinal microbiota and the immune system. Clin. Res. Hepatol. Gastroenterol. 2015, 39, 9–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rosenbaum, M.; Knight, R.; Leibel, R.L. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 2015, 26, 493–501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Indrio, F.; Riezzo, G.; Raimondi, F.; Di Mauro, A.; Francavilla, R. Microbiota involvement in the gut-brain axis. J. Pediatr. Gastroenterol. Nutr. 2013, 57, S11–S15. [Google Scholar] [CrossRef]
- Iebba, V.; Totino, V.; Gagliardi, A.; Santangelo, F.; Cacciotti, F.; Trancassini, M.; Mancini, C.; Cicerone, C.; Corazziari, E.; Pantanella, F.; et al. Eubiosis and dysbiosis: The two sides of the microbiota. New Microbiol. 2016, 39, 1–2. [Google Scholar] [PubMed]
- Belizário, J.E.; Napolitano, M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front. Microbiol. 2015, 6, 1050. [Google Scholar] [CrossRef]
- Edberg, S.C.; Rice, E.W.; Karlin, R.J.; Allen, M.J. Escherichia coli: The best biological drinking water indicator for public health protection. J. Appl. Microbiol. 2000, 88, 106S–116S. [Google Scholar] [CrossRef]
- Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the Human Intestinal Microbial Flora. Science 2005, 308, 1635–1638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leclerc, H.; Mossel, D.A.A.; Edberg, S.C.; Struijk, C.B. Advances in the Bacteriology of the Coliform Group: Their Suitability as Markers of Microbial Water Safety. Annu. Rev. Microbiol. 2001, 55, 201–234. [Google Scholar] [CrossRef]
- Sommer, F.; Anderson, J.M.; Bharti, R.; Raes, J.; Rosenstiel, P. The resilience of the intestinal microbiota influences health and disease. Nat. Rev. Microbiol. 2017, 15, 630–638. [Google Scholar] [CrossRef]
- Gigliucci, F.; von Meijenfeldt, F.A.; Knijn, A.; Michelacci, V.; Scavia, G.; Minelli, F.; Dutilh, B.E.; Ahmad, H.M.; Raangs, G.C.; Friedrich, A.W.; et al. Metagenomic Characterization of the Human Intestinal Microbiota in Fecal Samples from STEC-Infected Patients. Front. Cell. Infect. Microbiol. 2018, 8, 25. [Google Scholar] [CrossRef] [PubMed]
- Fijan, S. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature. Int. J. Environ. Res. Public Health 2014, 11, 4745–4767. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baldassarre, M.E.; Di Mauro, A.; Mastromarino, P.; Fanelli, M.; Martinelli, D.; Urbano, F.; Capobianco, D.; Laforgia, N. Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial. Nutrients 2016, 8, 677. [Google Scholar] [CrossRef] [PubMed]
- Baldassarre, M.E.; Di Mauro, A.; Tafuri, S.; Rizzo, V.; Gallone, M.S.; Mastromarino, P.; Capobianco, D.; Laghi, L.; Zhu, C.; Capozza, M.; et al. Effectiveness and Safety of a Probiotic-Mixture for the Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial with Fecal Real-Time PCR and NMR-Based Metabolomics Analysis. Nutrients 2018, 10, 195. [Google Scholar] [CrossRef] [PubMed]
- Szajewska, H.; Guarino, A.; Hojsak, I.; Indrio, F.; Kolacek, S.; Shamir, R.; Vandenplas, Y.; Weizman, Z. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J. Pediatr. Gastroenterol. Nutr. 2014, 58, 531–539. [Google Scholar] [CrossRef]
- Freedman, S.B.; Williamson-Urquhart, S.; Farion, K.J.; Gouin, S.; Willan, A.R.; Poonai, N.; Hurley, K.; Sherman, P.M.; Finkelstein, Y.; Lee, B.E.; et al. Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis. N. Engl. J. Med. 2018, 379, 2015–2026. [Google Scholar] [CrossRef] [PubMed]
- Wisener, L.V.; Sargeant, J.M.; O’connor, A.M.; Faires, M.C.; Glass-Kaastra, S.K. The use of direct-fed microbials to reduce shedding of Escherichia coli O157 in beef cattle: A systematic review and meta-analysis. Zoonoses Public Health 2015, 62, 75–89. [Google Scholar] [CrossRef] [PubMed]
- Sargeant, J.M.; Amezcua, M.R.; Rajic, A.; Waddell, L. Pre-harvest interventions to reduce the shedding of E. coli O157 in the faeces of weaned domestic ruminants: A systematic review. Zoonoses Public Health 2007, 54, 260–277. [Google Scholar] [CrossRef]
- Callaway, T.R.; Carr, M.A.; Edrington, T.S.; Anderson, R.C.; Nisbet, D.J. Diet, Escherichia coli O157: H7, and cattle: A review after 10 years. Curr. Issues Mol. Biol. 2009, 11, 67–79. [Google Scholar]
- Schnadower, D.; Tarr, P.I.; Casper, T.C.; Gorelick, M.H.; Dean, J.M.; O’connell, K.J.; Mahajan, P.; Levine, A.C.; Bhatt, S.R.; Roskind, C.G.; et al. Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children. N. Engl. J. Med. 2018, 379, 2002–2014. [Google Scholar] [CrossRef]
- Mogna, L.; Del Piano, M.; Deidda, F.; Nicola, S.; Soattini, L.; Debiaggi, R.; Sforza, F.; Strozzi, G.; Mogna, G. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli Strains. J. Clin. Gastroenterol. 2012, 46, S29–S32. [Google Scholar] [CrossRef] [PubMed]
- Rund, S.A.; Rohde, H.; Sonnenborn, U.; Oelschlaeger, T.A. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Int. J. Med. Microbiol. 2013, 303, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Tan, Q.; Xu, H.; Aguilar, ZP.; Peng, S.; Dong, S.; Wang, B.; Li, P.; Chen, T.; Xu, F.; Wei, H. Safety assessment and probiotic evaluation of Enterococcus faecium YF5 isolated from sourdough. Food Sci. 2013, 78, M587–M593. [Google Scholar] [CrossRef] [PubMed]
- Likotrafiti, E.; Tuohy, K.M.; Gibson, G.R.; Rastall, R.A. Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum. Anaerobe 2013, 20, 5–13. [Google Scholar] [CrossRef] [PubMed]
- Arena, M.P.; Russo, P.; Capozzi, V.; López, P.; Fiocco, D.; Spano, G. Probiotic abilities of riboflavin-overproducing Lactobacillus strains: A novel promising application of probiotics. Appl. Microbiol. Biotechnol. 2014, 98, 7569–7581. [Google Scholar] [CrossRef]
- Dini, C.; Bolla, P.A.; de Urraza, P.J. Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics. J. Appl. Microbiol. 2016, 121, 78–88. [Google Scholar] [CrossRef] [PubMed]
- Bian, X.; Evivie, S.E.; Muhammad, Z.; Luo, G.W.; Liang, H.Z.; Wang, N.N.; Huo, G.C. In vitro assessment of the antimicrobial potentials of Lactobacillus helveticus strains isolated from traditional cheese in Sinkiang China against food-borne pathogens. Food Funct. 2016, 7, 789–797. [Google Scholar] [CrossRef]
- Stöber, H.; Maier, E.; Schmidt, H. Protective effects of Lactobacilli, Bifidobacteria and Staphylococci on the infection of cultured HT29 cells with different enterohemorrhagic Escherichia coli serotypes are strain-specific. Int. J. Food Microbiol. 2010, 144, 133–140. [Google Scholar] [CrossRef]
- Tsai, Y.T.; Cheng, P.C.; Pan, T.M. Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice. J. Agric. Food Chem. 2010, 58, 11265–11272. [Google Scholar] [CrossRef]
- Hostetter, S.J.; Helgerson, A.F.; Paton, J.C.; Paton, A.W.; Cornick, N.A. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome. BMC Res. Notes 2014, 7, 331. [Google Scholar] [CrossRef]
- Peterson, R.E.; Klopfenstein, T.J.; Erickson, G.E.; Folmer, J.; Hinkley, S.; Moxley, R.A.; Smith, D.R. Effect of Lactobacillus acidophilus strain NP51 on Escherichia coli O157: H7 fecal shedding and finishing performance in beef feedlot cattle. J. Food Prot. 2007, 70, 287–291. [Google Scholar] [CrossRef]
- Rahal, E.A.; Fadlallah, S.M.; Nassar, F.J.; Kazzi, N.; Matar, G.M. Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype. Front. Cell. Infect. Microbiol. 2015, 5, 24. [Google Scholar] [CrossRef]
- Goldwater, P.N. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome. Expert Rev. Anti-Infect. Ther. 2007, 5, 653–663. [Google Scholar] [CrossRef]
- Etienne-Mesmin, L.; Livrelli, V.; Privat, M.; Denis, S.; Cardot, J.M.; Alric, M.; Blanquet-Diot, S. Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl. Environ. Microbiol. 2011, 77, 1127–1131. [Google Scholar] [CrossRef]
- Thévenot, J.; Cordonnier, C.; Rougeron, A.; Le Goff, O.; Nguyen, H.T.; Denis, S.; Alric, M.; Livrelli, V.; Blanquet-Diot, S. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer’s patches. Appl. Microbiol. Biotechnol. 2015, 99, 9097–9110. [Google Scholar] [CrossRef] [PubMed]
- Thévenot, J.; Etienne-Mesmin, L.; Denis, S.; Chalancon, S.; Alric, M.; Livrelli, V.; Blanquet-Diot, S. Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota. Appl. Environ. Microbiol. 2013, 79, 1058–1064. [Google Scholar] [CrossRef]
- Freedman, S. Pediatr. STEC Infection and the Front Line Clinician; VTEC: Florence, Italy, 2018. [Google Scholar]
- Baldassarre, M.E. Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota. Ann. Intern. Med. 2019, 170, 143. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Giordano, M.; Baldassarre, M.E.; Palmieri, V.; Torres, D.D.; Carbone, V.; Santangelo, L.; Gentile, F.; Panza, R.; Di Mauro, F.; Capozza, M.; et al. Management of STEC Gastroenteritis: Is There a Role for Probiotics? Int. J. Environ. Res. Public Health 2019, 16, 1649. https://doi.org/10.3390/ijerph16091649
Giordano M, Baldassarre ME, Palmieri V, Torres DD, Carbone V, Santangelo L, Gentile F, Panza R, Di Mauro F, Capozza M, et al. Management of STEC Gastroenteritis: Is There a Role for Probiotics? International Journal of Environmental Research and Public Health. 2019; 16(9):1649. https://doi.org/10.3390/ijerph16091649
Chicago/Turabian StyleGiordano, Mario, Maria Elisabetta Baldassarre, Viviana Palmieri, Diletta D. Torres, Vincenza Carbone, Luisa Santangelo, Federico Gentile, Raffaella Panza, Federica Di Mauro, Manuela Capozza, and et al. 2019. "Management of STEC Gastroenteritis: Is There a Role for Probiotics?" International Journal of Environmental Research and Public Health 16, no. 9: 1649. https://doi.org/10.3390/ijerph16091649